Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice

被引：705

作者：

Hanahan, D ^{[1
]}

Bergers, G

Bergsland, E

机构：

[1] Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA

[2] Univ Calif San Francisco, Dept Biophys, San Francisco, CA 94143 USA

[3] Univ Calif San Francisco, Hormone Res Inst, San Francisco, CA 94143 USA

[4] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA

来源：

JOURNAL OF CLINICAL INVESTIGATION | 2000年 / 105卷 / 08期

关键词：

D O I：

10.1172/JCI9872

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 [基础医学];

摘要：

引用

页码：1045 / 1047

页数：3

共 23 条

[1]

Safety and antitumor activity of recombinant soluble Apo2 ligand [J].

Ashkenazi, A ;

Pai, RC ;

Fong, S ;

Leung, S ;

Lawrence, DA ;

Masters, SA ;

Blackie, C ;

Chang, L ;

McMurtrey, AE ;

Hebert, A ;

DeForge, L ;

Koumenis, IL ;

Lewis, D ;

Harris, L ;

Bussiere, J ;

Koeppen, H ;

Shahrokh, Z ;

Schwall, RH .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :155-162

[2]

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal [J].

Benjamin, LE ;

Golijanin, D ;

Itin, A ;

Pode, D ;

Keshet, E .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :159-165

[3]

INEFFICACY OF LOW-DOSE CONTINUOUS ORAL ETOPOSIDE IN NONSMALL CELL LUNG-CANCER [J].

BLUMENREICH, MS ;

SHETH, SP ;

MILLER, CL ;

FARNSLEY, ES ;

KELLIHAN, MJ ;

JOSEPH, UG ;

HAMM, JT ;

SEEGER, J ;

ROBINSON, LH ;

HAGAN, PC ;

SULLIVAN, DM ;

WOODCOCK, TM .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (02) :163-165

[4]

Browder T, 2000, CANCER RES, V60, P1878

[5]

Burris H, 1998, SEMIN ONCOL, V25, P21

[6]

THALIDOMIDE IS AN INHIBITOR OF ANGIOGENESIS [J].

DAMATO, RJ ;

LOUGHNAN, MS ;

FLYNN, E ;

FOLKMAN, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :4082-4085

[7]

FOLKMAN J, 2000, CANC MED

[8]

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis [J].

Hanahan, D ;

Folkman, J .

CELL, 1996, 86 (03) :353-364

[9]

The hallmarks of cancer [J].

Hanahan, D ;

Weinberg, RA .

CELL, 2000, 100 (01) :57-70

[10]

Replication-selective adenoviruses as oncolytic agents [J].

Heise, C ;

Kirn, DH .

JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (07) :847-851

← 1 2 3 →